Souhaitez-vous accéder aux communiqués récents ?

New Taipei City, Taiwan, June 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and...

$452.5 million in total milestone payments$2.5 million in near-term paymentsDouble-digit royalties on future net product sales3.5% equity stake in Intact Therapeutics HANOVER, Md., June 17, 2025 ...

Liv Hospital & Istinye Univ forge groundbreaking alliance with UPenn’s Perelman School to advance CAR T/proton therapy access and medical research in TR.

Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment of platinum resistant ovarian cancer (PROC)...

OAKLAND, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Alameda Health System (AHS) patients experiencing the sudden and frightening symptoms of a stroke will now receive faster and more-integrated...

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- Stroke can happen anytime, anywhere and to anyone. In the US, there are approximately 800,000 strokes a year, among people of all ages. May is Stroke...

New contingency management program now available at Porch Light Health for substance use treatment

Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move forward with Cohort 2. The company plans on releasing more detailed...

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...

MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic...